Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cardiovascular Drugs and Therapy
Published in: Cardiovascular Drugs and Therapy 4/2006

01-08-2006 | Basic pharmacology – Myocardial Infarction

Therapeutic Effectiveness of a Single vs Multiple Doses of Erythropoietin After Experimental Myocardial Infarction in Rats

Authors: Chanil Moon, Melissa Krawczyk, Edward G. Lakatta, Mark I. Talan

Published in: Cardiovascular Drugs and Therapy | Issue 4/2006

Login to get access
Metadata
Title
Therapeutic Effectiveness of a Single vs Multiple Doses of Erythropoietin After Experimental Myocardial Infarction in Rats
Authors
Chanil Moon
Melissa Krawczyk
Edward G. Lakatta
Mark I. Talan
Publication date
01-08-2006
Publisher
Kluwer Academic Publishers
Published in
Cardiovascular Drugs and Therapy / Issue 4/2006
Print ISSN: 0920-3206
Electronic ISSN: 1573-7241
DOI
https://doi.org/10.1007/s10557-006-0080-z

Other articles of this Issue 4/2006

Cardiovascular Drugs and Therapy 4/2006 Go to the issue

Pharmaco-Economics

The Cost-Effectiveness of Fluvastatin in Hungary Following Successful Percutaneous Coronary Intervention

Editorial

Healing Unhealthy Hungarian Hearts – At What Cost? – With What Benefit?

Short Communication

A Potential Role for PTEN in the Diabetic Heart

Basic Pharmacology – Endothelial Function

Pravastatin Prevents Myocardium from Ischemia-Induced Fibrosis by Protecting Vascular Endothelial Cells Exposed to Oxidative Stress

Basic Pharmacology – Endothelial Function

Probucol Decreases Asymmetrical Dimethylarginine Level by Alternation of Protein Arginine Methyltransferase I and Dimethylarginine Dimethylaminohydrolase Activity

Basic Pharmacology – Cardiac Hypertrophy

Fosinopril and Carvedilol Reverse Hypertrophy and Change the Levels of Protein Kinase Cɛ and Components of its Signaling Complex

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits